These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of nuclear medicine in inflammatory bowel disease. A review with experiences of aspecific bowel activity using immunoscintigraphy with 99mTc anti-granulocyte antibodies. Györke T, Duffek L, Bártfai K, Makó E, Karlinger K, Mester A, Tarján Z. Eur J Radiol; 2000 Sep; 35(3):183-92. PubMed ID: 11000561 [Abstract] [Full Text] [Related]
27. Tc-99m HMPAO white blood cell scintigraphy in the assessment of the extent and severity of an acute exacerbation of ulcerative colitis. Bennink R, Peeters M, D'Haens G, Rutgeerts P, Mortelmans L. Clin Nucl Med; 2001 Feb; 26(2):99-104. PubMed ID: 11201494 [Abstract] [Full Text] [Related]
28. Quantitative assessment of overall inflammatory bowel disease activity using labelled leucocytes: a direct comparison between indium-111 and technetium-99m HMPAO methods. Mansfield JC, Giaffer MH, Tindale WB, Holdsworth CD. Gut; 1995 Nov; 37(5):679-83. PubMed ID: 8549945 [Abstract] [Full Text] [Related]
29. (99m)Tc antigranulocyte monoclonal antibody imaging for the detection and assessment of inflammatory bowel disease newly diagnosed by colonoscopy in children. Charron M, Di Lorenzo C, Kocoshis SA, Hickeson MP, Orenstein SR, Goyal A, Kahn S, Collins L. Pediatr Radiol; 2001 Nov; 31(11):796-800. PubMed ID: 11692237 [Abstract] [Full Text] [Related]
35. The diagnostic value of Tc-99m human polyclonal immunoglobulin imaging compared to Tc-99m HMPAO labeled leukocytes in inflammatory bowel disease. Delgado Castro M, Lancha C, Prats E, Mitjavilla M, Abós D, Martín-Curto LM, Crespo A, Banzo J. Clin Nucl Med; 1997 Jan; 22(1):17-20. PubMed ID: 8993867 [Abstract] [Full Text] [Related]